Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2730 (114th)

National Prostate Cancer Plan Act

referredUnited States· United States Congress· EN

Introduced

11 June 2015

Last action

12 June 2015 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Butterfield, G. K. [D-NC-1], Rep. McCaul, Michael T. [R-TX-10], Rep. Cummings, Elijah E. [D-MD-7], Rep. Jones, Walter B., Jr. [R-NC-3], Rep. Kelly, Robin L. [D-IL-2], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Whitfield, Ed [R-KY-1], Rep. Ellmers, Renee L. [R-NC-2], Rep. Beatty, Joyce [D-OH-3], Rep. Hastings, Alcee L. [D-FL-20], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Frelinghuysen, Rodney P. [R-NJ-11]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Summary

National Prostate Cancer Plan Act Establishes in the Department of Health and Human Services (HHS) the National Prostate Cancer Council on Screening, Early Detection, Assessment, and Monitoring of Prostate Cancer to: (1) develop and implement a strategic plan for the accelerated development of diagnostic tools for prostate cancer, (2) review the effectiveness of diagnostic tools for prostate cancer, (3) coordinate prostate cancer research and services across federal agencies, (4) evaluate all active federal prostate cancer programs, and (5) ensure the inclusion of men at high risk for prostate cancer in clinical, research, and service efforts. Directs the Council to submit annual reports. Requires the first report to include recommendations based on an evaluation of prostate cancer research and gaps in the development and validation of diagnostic tools for prostate cancer. Requires subsequent reports to include an outline for a national research plan, roles for specified agencies, an analysis of the disparities in the incidence and mortality of prostate cancer in high-risk men, and a review of the progress towards the realization of the strategic plan. Terminates the Council on December 31, 2020.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 June 2015

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 11 June 2015

    Introduced

    Sponsor introductory remarks on measure. (CR H4388)

    Source: IntroReferral

  3. 11 June 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 11 June 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 12 June 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 11 June 2015

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 11 June 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 11 June 2015

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.